SonoScape Medical Corp. / Fundamentals
Income statement
- Net revenue
€236.73M - Cost of goods sold
€92.15M - Gross profit
€144.58M - SG&A expenses
€30.90M - R&D expenses
€60.80M - EBITDA
-€1.83M - D&A
€0.00 - EBIT
-€2.50M - Interest expenses
€771.70K - EBT
-€2.61M - Tax expenses
-€4.88M - Net income
€2.27M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€20.04M - Changes in working capital
€0.00 - Operating cash flow
-€27.46M - Capex
€19.67M - Other investing cash flow
-€51.15M - Net investing cash flow
€27.41M - Total cash dividends paid
-€5.99M - Issuance of common stock
€0.00 - Debt repayment
-€21.17M - Other financing cash flow
-€7.02M - Net financing cash flow
-€34.17M - Foreign exchange effects
-€174.29K - Net change in cash
-€1.97M - Cash at end of period
€176.64M - Free cash flow
-€7.79M
Balance sheet
- Cash and cash equivalents
€182.01M - Cash and short-term investments
€182.19M - Total receivables
€25.37M - Inventory
€94.87M - Other current assets
€11.22M - Total current assets
€313.66M - Property, plant & equipment
€119.07M - Goodwill
€13.47M - Intangible assets
€17.99M - Long-term investments
€1.10M - Other non-current assets
€10.72M - Total non-current assets
€170.27M - Total assets
€483.93M - Accounts payable
€33.64M - Short-term debt
€22.14M - Other current liabilities
€36.37M - Total current liabilities
€94.92M - Long-term debt
€8.28M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€13.76M - Total liabilities
€108.67M - Common stock
€52.12M - Retained earnings
€170.67M - Other equity
€37.97M - Total equity
€375.25M - Total liabilities and shareholders' equity
€483.93M
Company information
- Market capitalization
€1.52B - Employees
3.1K - Enterprise Value
€12.81B
Company ratios
- Gross margin
-
61.1% Even with peer group: 61.9% - EBITDA margin
-
-0.8% Much worse than peer group: 30.6% - EBIT margin
-
-1.1% Much worse than peer group: 27.5% - EBT margin
-
-1.1% Much worse than peer group: 27.8% - Net margin
-
1.0% Much worse than peer group: 23.1% - ROE
-
0.6% Worse than peer group: 13.2% - ROA
-
0.5% Worse than peer group: 9.6% - Asset turnover
-
48.9% Better than peer group: 42.9% - FCF margin
-
-19.9% Much worse than peer group: 4.6% - FCF yield
-3.1% - Efficiency ratio
100.8% - Net sales per employee
-
€75.83K - Net income per employee
-
€727.40